Edward T. Creagan et al., 1979-09-27: Double-blind randomised trial in 150 patients with advanced cancer comparing 10 g/day vitamin C with a lactose placebo; the groups were similar in previous chemotherapy. There was no difference in symptoms, performance status, appetite, weight or survival (median about seven weeks in both arms).
In this selected group of patients, we were unable to show a therapeutic benefit of high-dose vitamin C treatment.
Abstract, unpaginated web record
Edward T. Creagan et al., 1979-09-27: Double-blind randomised trial in 150 patients with advanced cancer comparing 10 g/day vitamin C with a lactose placebo; the groups were similar in previous chemotherapy. There was no difference in symptoms, performance status, appetite, weight or survival (median about seven weeks in both arms). Funder: not stated in the abstract (Mayo Clinic Comprehensive Cancer Center, NCI-funded programme). Maker: generic ascorbic acid. Comparator: identically flavoured lactose placebo, randomised and double-blind – the design the Cameron-Pauling work lacked. Conflicts: none declared. 60 evaluable on vitamin C, 63 on placebo. Note the trial enrolled patients excluded by Cameron and Pauling, a criticism the authors of CHF-11 made and that Moertel's group answered with CHF-13. Study type: randomized trial.
